FR2525603A1 - Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique - Google Patents
Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique Download PDFInfo
- Publication number
- FR2525603A1 FR2525603A1 FR8207203A FR8207203A FR2525603A1 FR 2525603 A1 FR2525603 A1 FR 2525603A1 FR 8207203 A FR8207203 A FR 8207203A FR 8207203 A FR8207203 A FR 8207203A FR 2525603 A1 FR2525603 A1 FR 2525603A1
- Authority
- FR
- France
- Prior art keywords
- spiro
- formula
- salt
- dione
- isoquinoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (22)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8207203A FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
AT0125383A ATA125383A (de) | 1982-04-27 | 1983-04-08 | Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen |
DD83250187A DD209833A5 (de) | 1982-04-27 | 1983-04-25 | Verfahren zur herstellung von benzoazacycloalkyl-spiro-imidazolidinen |
LU84770A LU84770A1 (fr) | 1982-04-27 | 1983-04-25 | Benzoazacycloalkyl-spiro-imidazolidines,leur preparation et leur application en therapeutique |
PT76595A PT76595B (fr) | 1982-04-27 | 1983-04-26 | Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines |
DK183583A DK183583A (da) | 1982-04-27 | 1983-04-26 | Fremgangsmaade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner |
SE8302347A SE8302347L (sv) | 1982-04-27 | 1983-04-26 | Bensoazacykloalkyl-spiro-imidazolidiner, framstellning derav och farmaceutiska kompositioner innehallande dem |
KR1019830001753A KR840004428A (ko) | 1982-04-27 | 1983-04-26 | 벤조 아자시클로 알킬-스피로-이미다졸리딘의 제조방법 |
IL68497A IL68497A0 (en) | 1982-04-27 | 1983-04-26 | Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them |
BE0/210633A BE896572A (fr) | 1982-04-27 | 1983-04-26 | Benzoazacycloalkyl-spiro-imidazolidines leur preparation et leur application en therapeutique |
ZA832927A ZA832927B (en) | 1982-04-27 | 1983-04-26 | Benzoazacycloalkyl-spiro-imidazolidines,their preparation and compositions containing them |
AU13953/83A AU1395383A (en) | 1982-04-27 | 1983-04-26 | Benzoazacycloalkyl-spiro-imidazolidines |
NL8301476A NL8301476A (nl) | 1982-04-27 | 1983-04-26 | Benzoazacycloalkylspiroimidazolidines, hun bereiding en farmaceutische samenstellingen welke deze bevatten. |
GR71214A GR78481B (es) | 1982-04-27 | 1983-04-26 | |
IT48155/83A IT1167123B (it) | 1982-04-27 | 1983-04-26 | Benzoazacicloalchilspiro-imidazolidine,procedimento per prepararle e composizioni farmaceutiche che le contengono |
NO831473A NO831473L (no) | 1982-04-27 | 1983-04-26 | Fremgangsmaate ved fremstilling av benzoazacykloalkyl-spiro-imidazolidiner |
JP58073687A JPS5910584A (ja) | 1982-04-27 | 1983-04-26 | イミダゾリジン誘導体 |
DE19833315106 DE3315106A1 (de) | 1982-04-27 | 1983-04-27 | Benzoazacycloalkyl-spiro-imidazolidine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen |
MA20003A MA19783A1 (fr) | 1982-04-27 | 1983-04-27 | Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines. |
ES521895A ES8405796A1 (es) | 1982-04-27 | 1983-04-27 | Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables. |
OA57984A OA07412A (fr) | 1982-04-27 | 1983-04-27 | Benzoazacycloalhyl-spiro-imidazolidines leur préparation et leur application en thérapeutique. |
GB08311508A GB2133401B (en) | 1982-04-27 | 1983-04-27 | Benzoazacycloalkyl-spiro-imidazolidines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8207203A FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2525603A1 true FR2525603A1 (fr) | 1983-10-28 |
FR2525603B1 FR2525603B1 (es) | 1984-09-14 |
Family
ID=9273425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8207203A Granted FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPS5910584A (es) |
KR (1) | KR840004428A (es) |
AT (1) | ATA125383A (es) |
AU (1) | AU1395383A (es) |
BE (1) | BE896572A (es) |
DD (1) | DD209833A5 (es) |
DE (1) | DE3315106A1 (es) |
DK (1) | DK183583A (es) |
ES (1) | ES8405796A1 (es) |
FR (1) | FR2525603A1 (es) |
GB (1) | GB2133401B (es) |
GR (1) | GR78481B (es) |
IL (1) | IL68497A0 (es) |
IT (1) | IT1167123B (es) |
LU (1) | LU84770A1 (es) |
MA (1) | MA19783A1 (es) |
NL (1) | NL8301476A (es) |
NO (1) | NO831473L (es) |
OA (1) | OA07412A (es) |
PT (1) | PT76595B (es) |
SE (1) | SE8302347L (es) |
ZA (1) | ZA832927B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
PL2332921T3 (pl) | 2003-06-17 | 2016-08-31 | Arena Pharm Inc | Chlorowodorek 8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny |
EP2332920A3 (en) | 2003-06-17 | 2011-12-21 | Arena Pharmaceuticals, Inc. | Processes for preparing 3-benzazepines |
NZ555981A (en) | 2004-12-21 | 2011-01-28 | Arena Pharm Inc | Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
NZ555482A (en) | 2004-12-23 | 2011-01-28 | Arena Pharm Inc | Compositions comprising a 5HT2C receptor modulator and 2-methylamphetamine and methods of use |
EP2471779A1 (en) | 2006-04-03 | 2012-07-04 | Arena Pharmaceuticals, Inc. | Process for the resolution of a mixture of (R)- and (S)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
ES2522587T3 (es) | 2006-12-05 | 2014-11-17 | Arena Pharmaceuticals, Inc. | Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma |
WO2009111004A1 (en) | 2008-03-04 | 2009-09-11 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ht2c 수용체 아고니스트의 제조 방법 |
CN103347523A (zh) | 2010-09-01 | 2013-10-09 | 艾尼纳制药公司 | 向具有肾损伤的个体给药氯卡色林 |
WO2012030957A2 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-ht2c agonists |
KR20180118801A (ko) | 2010-09-01 | 2018-10-31 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태 |
CA2808909A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
BR112015007779A2 (pt) | 2012-10-09 | 2017-07-04 | Arena Pharm Inc | célula de fluxo de permeabilidade e sistema de condutância hidráulica |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0021704A1 (en) * | 1979-06-13 | 1981-01-07 | Pfizer Inc. | Spiro-hydantoin derivatives, process for their preparation and pharmaceutical compositions thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4209630A (en) * | 1976-10-18 | 1980-06-24 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
-
1982
- 1982-04-27 FR FR8207203A patent/FR2525603A1/fr active Granted
-
1983
- 1983-04-08 AT AT0125383A patent/ATA125383A/de not_active IP Right Cessation
- 1983-04-25 DD DD83250187A patent/DD209833A5/de unknown
- 1983-04-25 LU LU84770A patent/LU84770A1/fr unknown
- 1983-04-26 JP JP58073687A patent/JPS5910584A/ja active Pending
- 1983-04-26 GR GR71214A patent/GR78481B/el unknown
- 1983-04-26 BE BE0/210633A patent/BE896572A/fr not_active IP Right Cessation
- 1983-04-26 IL IL68497A patent/IL68497A0/xx unknown
- 1983-04-26 IT IT48155/83A patent/IT1167123B/it active
- 1983-04-26 PT PT76595A patent/PT76595B/pt unknown
- 1983-04-26 AU AU13953/83A patent/AU1395383A/en not_active Abandoned
- 1983-04-26 NL NL8301476A patent/NL8301476A/nl not_active Application Discontinuation
- 1983-04-26 NO NO831473A patent/NO831473L/no unknown
- 1983-04-26 ZA ZA832927A patent/ZA832927B/xx unknown
- 1983-04-26 KR KR1019830001753A patent/KR840004428A/ko not_active Application Discontinuation
- 1983-04-26 DK DK183583A patent/DK183583A/da not_active Application Discontinuation
- 1983-04-26 SE SE8302347A patent/SE8302347L/xx not_active Application Discontinuation
- 1983-04-27 ES ES521895A patent/ES8405796A1/es not_active Expired
- 1983-04-27 DE DE19833315106 patent/DE3315106A1/de not_active Withdrawn
- 1983-04-27 OA OA57984A patent/OA07412A/xx unknown
- 1983-04-27 MA MA20003A patent/MA19783A1/fr unknown
- 1983-04-27 GB GB08311508A patent/GB2133401B/en not_active Expired
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0021704A1 (en) * | 1979-06-13 | 1981-01-07 | Pfizer Inc. | Spiro-hydantoin derivatives, process for their preparation and pharmaceutical compositions thereof |
Also Published As
Publication number | Publication date |
---|---|
ATA125383A (de) | 1986-05-15 |
SE8302347L (sv) | 1983-10-28 |
DE3315106A1 (de) | 1983-11-03 |
KR840004428A (ko) | 1984-10-15 |
LU84770A1 (fr) | 1984-11-28 |
SE8302347D0 (sv) | 1983-04-26 |
DK183583A (da) | 1983-10-28 |
ES521895A0 (es) | 1984-06-16 |
AU1395383A (en) | 1983-11-03 |
BE896572A (fr) | 1983-10-26 |
IT1167123B (it) | 1987-05-13 |
FR2525603B1 (es) | 1984-09-14 |
DD209833A5 (de) | 1984-05-23 |
NO831473L (no) | 1983-10-28 |
GR78481B (es) | 1984-09-27 |
NL8301476A (nl) | 1983-11-16 |
PT76595B (fr) | 1986-01-21 |
PT76595A (fr) | 1983-05-01 |
IL68497A0 (en) | 1983-07-31 |
ES8405796A1 (es) | 1984-06-16 |
MA19783A1 (fr) | 1983-12-31 |
JPS5910584A (ja) | 1984-01-20 |
IT8348155A0 (it) | 1983-04-26 |
GB8311508D0 (en) | 1983-06-02 |
GB2133401A (en) | 1984-07-25 |
OA07412A (fr) | 1984-11-30 |
ZA832927B (en) | 1984-06-27 |
GB2133401B (en) | 1985-10-23 |
DK183583D0 (da) | 1983-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2525603A1 (fr) | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique | |
US4200642A (en) | Spiro-oxazolidindiones | |
EP0202164B1 (fr) | Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique | |
EP0281459A1 (fr) | Enantiomère dextrogyre de l'alpha-(tétrahydro-4,5,6,7 thiéno (3,2-c)pyridyl-5) (chloro-2 phényl)-acétate de méthyle, son procédé de préparation et les compositions pharmaceutiques le renfermant | |
WO1985004652A1 (fr) | Derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications | |
CA2176668C (fr) | Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant | |
EP0370901A1 (fr) | Nouveaux dérivés du chromanne actifs sur le système nerveux central, leur procédé de préparation et les compositions pharmaceutiques en contenant | |
US4283539A (en) | Isoquinoline acetic acids | |
EP0051023A1 (fr) | Nouveaux composés appartenant à la famille des benzoyl- et alpha-hydroxybenzyl-phényl-osides, leur procédé de préparation et leur application en thérapeutique | |
FR2620121A1 (fr) | ((pyrimidinyl-2)-aminoalkyl)-1 piperidines, leur preparation et leur application en therapeutique | |
EP0350403A1 (fr) | Dérivés de (aza)naphtalènesultame, leurs procédés de préparation et les médicaments les contenant | |
EP0125195B1 (fr) | Nouveaux acides flavonecarboxyliques-4', leur méthode de préparation et leur application thérapeutique | |
EP0319412B1 (fr) | Nouveaux dérivés flavonoides pipérazinyl-2 oxo-2 éthylène substitués, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent | |
US4134991A (en) | Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid | |
EP0479631A1 (fr) | Dérivés du spiro [4.5]décane leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
BE1009852A3 (fr) | Derives 1-[2(vinyl-substitues)]-3-4-dihydro-5h-2,3-benzodiazepine. | |
US4025649A (en) | Acetic acid derivatives having pharmacological activity and compositions containing the same | |
EP0004494A1 (fr) | Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant | |
EP0301936B1 (fr) | Dérivés de pipéridine, leur préparation et leur application en thérapeutique | |
EP0074903A2 (fr) | Dérivés d'amino-2 tétrahydro-1,2,3,4 naphtalène, leur préparation et leur application en thérapeutique | |
FR2610932A1 (fr) | Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament | |
JPS61286359A (ja) | N−〔〔5−(トリフルオロメチル)−6−メトキシ−1−ナフタレニル〕チオキソメチルまたはカルボニル〕−n−メチルグリシンアミド | |
FR2508457A1 (fr) | Pyrrolo(2,1-b)quinazolines et pyrido(2,1-b)quinazolines substituees, leur preparation et leurs utilisations therapeutiques | |
EP0002401B1 (fr) | Dérivés de naphtalène, leur préparation et leur application en thérapeutique | |
EP0427605B1 (fr) | Nouveaux dérivés de la morpholine, leur procédé de préparation et les compositions pharmaceutiques les renfermant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |